#	Pagina
attuale pagina	/open-h2020/projects/197525/index.html
-1	/open-h2020/projects/225952/index.html
-2	/open-h2020/projects/194035/index.html
-3	/open-h2020/projects/198699/index.html

Opendata, web and dolomites

SAMPA SIGNED

Scale-up of an Advanced Manufacturing process to produce a Pharmaceutical product Application (SAMPA).

Total Cost €

EC-Contrib. €

Partnership

Views

Outcomes and
results

SAMPA project word cloud

Explore the words cloud of the SAMPA project. It provides you a very rough idea of what is the project "SAMPA" about.

severe cycol 500m pharma batches batch scaling treat jobs successful inflamed drugs pharmaceutical underlying unlock sigmoid requested parallel skill serious drug retain moderate inherent expensive significantly enabled months 50kg million completion providers involve proprietary probability human 21 pivot suppliers disease colons smpill powerful safe 5kg cyclosporine specialist oral commercialisation nanoemulsion 6m injected reg intellectual sme innovative size company npv patients property budget platform colitis manufacturing sampa compete risk ulcerative proven

Project "SAMPA" data sheet

The following table provides information about the project.

Coordinator	SIGMOID PHARMA LIMITED Organization address address: THE INVENT CENTRE, DUBLIN CITY UNIVERSITY city: DUBLIN postcode: 9 website: www.sigmoidpharma.com contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Ireland [IE]
Project website	https://www.sublimitytherapeutics.com/about/sampa-grant/
Total cost	2˙307˙500 €
EC max contribution	1˙600˙000 € (69%)
Programme	1. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument) 2. H2020-EU.2.1.2. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies)
Code Call	H2020-SMEINST-2-2014
Funding Scheme	SME-2
Starting year	2015
Duration (year-month-day)	from 2015-07-01 to 2017-03-31

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	SIGMOID PHARMA LIMITED SIGMOID PHARMA LIMITED Organization address address: THE INVENT CENTRE, DUBLIN CITY UNIVERSITY city: DUBLIN postcode: 9 website: www.sigmoidpharma.com contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	IE (DUBLIN)	coordinator	1˙600˙000.00

Map

Project objective

Sigmoid Pharma has developed an innovative product, CyCol®, to treat patients with moderate-severe ulcerative colitis, a disease that affects 1 million patients in Europe. CyCol® is enabled using Sigmoid’s proprietary SmPill® nanoemulsion-based technology to target a known and powerful drug, cyclosporine, directly to inflamed colons. In Phase II human studies, CyCol® was proven to be effective and safe. CyCol®, on oral product, will compete with injected, expensive drugs that have a risk of serious side effects.

Successful development and commercialisation of CyCol® will pivot on scaling up the advanced manufacturing process from the current ~5kg to the ~50kg batch size required for Phase III human studies.

SAMPA (Scale-up of an Advanced Manufacturing process to produce a Pharmaceutical product Application) project is focused on achieving 50kg batches. It will involve leading EU-based specialist SME technology and equipment suppliers as well as a number of knowledge providers. The requested budget is €1.6M and will be completed in 21 months.

Successful completion of this project will retain and enhance intellectual property and know-how in Sigmoid, increase long term high skill jobs. In parallel, the project will unlock the value inherent not only of CyCol®, but also the underlying SmPill® technology platform. Furthermore, the project will increase the probability of overall company success and increase significantly the NPV to more than €500M.

Deliverables

List of deliverables.
Project website	Websites, patent fillings, videos etc.	2019-11-28 17:28:20

Take a look to the deliverables list in detail: detailed list of SAMPA deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SAMPA" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SAMPA" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.3.1.;H2020-EU.2.1.2.)

S3D (2015)

Feasibility study to determine the use of ITS technology to replace nuclear density meters in mining, dredging and other areas of hydraulic transport.